Fatty liver disease has become a health problem related to metabolic syndrome worldwide, although its molecular pathogenesis requires further study. It is also unclear whether advanced fibrosis of steatohepatitis will regress when diet is controlled. The aim of this study was to investigate whether the resolution of fibrosis occurs in steatohepatitis induced by a methionine-choline-deficient diet (MCDD). Manifestation of endoplasmic reticulum (ER) stress in this model was also studied. Nonalcoholic steatohepatitis with advanced fibrosis was induced in rats by feeding them an MCDD for 10 weeks. Instead of MCDD, a methionine-choline control diet (CD) was given for the last 2 weeks to the experimental group. Fibrosis and inflammation were determined by tissue staining. Protein and gene expressions were determined by immunoblotting and quantitative reverse transcription-PCR (RT-PCR), respectively. Expressions of caspase-7, caspase-12, glucose-regulated protein 78 (GRP78), and protein disulfide isomerase were evaluated to clarify the presence of ER stress. Changing the diet from MCDD to CD triggered the reduction of fat in hepatocytes, a decrease in inflammatory gene expression and oxidative stress, and regression of fibrosis accompanied by the disappearance of activated stellate cells and macrophages. Immunohistochemistry, immunoblotting, and RT-PCR analysis all indicated the occurrence of ER stress in steatohepatitis, while it recovered immediately after changing the diet from MCCD to CD. The ratio of hepatocyte proliferation/apoptotis increased significantly during the recovery stage. This simple experiment clearly shows that changing the diet from MCDD to a normal diet (CD) triggers the resolution of hepatic inflammatory and fibrotic reactions and hepatocyte apoptosis, suggesting that MCDD-induced steatohepatitis is also reversible. ER stress appears and disappears in association with the generation and regression of steatohepatitis, respectively, with fibrosis.
Nonalcoholic fatty liver disease (NAFLD) is a relatively newly defined hepatic sequela of obesity and type II diabetes mellitus, [1] [2] [3] and it is one of the most common causes of chronic liver disease in many countries. 4 A number of studies have identified a significant correlation between hepatic steatosis and fibrosis. [5] [6] [7] NAFLD covers a progressive spectrum of liver pathologies from simple steatosis to nonalcoholic steatohepatitis (NASH), which is characterized by necroinflammation and fibrosis, and, subsequently, by cirrhosis. 8 It is also speculated that NASH may progress to hepatocellular carcinoma. [9] [10] [11] Although adipocytokines, cytokines, and free fatty acids (FFAs) derived from peripheral and visceral fat tissues, which are known as mediators of metabolic syndrome, are assumed to contribute to the initiation of inflammatory reactions in the liver, the link between the development of hepatic steatosis and fibrosis is still poorly understood. 12 Furthermore, whether the regression of liver fibrosis caused by NASH occurs after controlling diet has not been proven, but the reversibility of liver fibrosis has been evidenced in patients who have successfully achieved the eradication of hepatitis C virus after interferon therapy. 13, 14 Over the past decade, it has become clear that obesity is associated with the activation of cellular stress signaling and inflammatory pathways. [15] [16] [17] A key cell organelle in cellular stress response is the endoplasmic reticulum (ER), a membranous network that functions in the synthesis and processing of secreted and membranous proteins. Certain pathological stress conditions disrupt ER homeostasis and lead to the accumulation of unfolded or misfolded proteins in the ER lumen, known as ER stress, resulting in the activation of signal transduction systems. [18] [19] [20] ER stress is caused by glucose or nutrient deprivation, viral infections, lipids, increased synthesis of secretory proteins, and expression of mutant or misfolded proteins, and has been recently implicated in human diseases, such as Alzheimer's disease, Parkinson's disease, diabetes mellitus, and liver disease. [21] [22] [23] [24] In this study, a rat steatohepatitis model induced by a methionine-choline-deficient diet (MCDD) for 10 weeks was used to obtain evidence for the resolution of fibrosis in fatty liver after changing the diet to a methionine-choline control diet (CD). The manifestation of ER stress was also studied. The results of this study clearly indicated that a dietary change from MCDD to CD immediately initiates tissue remodeling, which is associated with the cessation of cellular apoptosis and ER stress.
MATERIALS AND METHODS Materials
Mouse monoclonal antibody against a-smooth muscle actin (a-SMA, Clone 1A4) and mouse monoclonal antibody against 5-bromo-2-deoxyuridine (BrdU, Clone 1BU33, 1:1000) were obtained from Sigma Chemical (St Louis, MO, USA). Rat monoclonal antibody against caspase-12 and goat polyclonal antibodies against glucose-regulated protein 78 (GRP78) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal antibodies against caspase-7, rabbit polyclonal antibodies against cleaved caspase-7 (Asp198), and rabbit polyclonal antibodies against protein disulfide isomerase (PDI) were obtained from Cell Signaling Technology (Danvers, MA, USA). Mouse monoclonal antibody against CD68 (Clone, KP1) was purchased from Dako Denmark A/S (Glostrup, Denmark). Mouse monoclonal antibody against heme oxygenase-1 (HO-1, Hsp32) was obtained from Assay Designs (Ann Arbor, MI, USA). Mouse monoclonal antibody against 4-hydroxy-2-nonenal (4-HNE) was purchased from the Japan Institute for the Control of Aging (Shizuoka, Japan). Mouse monoclonal antibody against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was obtained from Chemicon International (Temecula, CA, USA). Rabbit anti-cytoglobin antibodies were produced in our laboratory as described previously. 25 Horseradish peroxidase (HRP)-conjugated polyclonal rabbit anti-goat immunoglobulins, HRP-conjugated polyclonal rabbit anti-mouse immunoglobulins, HRP-conjugated polyclonal rabbit anti-rat immunoglobulins, and HRP-conjugated polyclonal swine anti-rabbit immunoglobulins were obtained from Dako Denmark A/S. Hybond-ECL nitrocellulose membranes and ECL detection reagent were obtained from Amersham Pharmacia Biotech (Buckinghamshire, UK). All other reagents were purchased from Sigma Chemical or Wako Pure Chemical.
Animals and Experimental Protocol
Pathogen-free male Wistar rats (7-8 weeks of age) were obtained from SLC (Shizuoka, Japan). Animals were housed at a constant temperature and supplied with laboratory chow and water ad libitum. The experimental protocol was approved by the Animal Research Committee of Osaka City University (Guide for Animal Experiments, Osaka City University).
The rats were fed a CD (group C, n ¼ 5) or MCDD (group M, n ¼ 5) for 10 weeks. The contents of MCDD and CD are listed in Supplementary Table 1 . A recovery model (group R, n ¼ 5) was produced by administering MCDD for 8 weeks and thereafter CD for 2 weeks. During the experimental period, individual body weights were recorded twice per week (see Supplementary Table 2 ).
Sample Harvesting
At the end of the tenth week, rats were killed under ether anesthesia, and the portal vein was cannulated using an 18-G Teflon catheter. Blood samples were collected from the inferior vena cava, centrifuged at 3000 r.p.m. for 30 min at 41C, and the obtained sera were kept at À701C until further use for serum chemistry tests. The liver of each animal was perfused with 100 ml of phosphate-buffered saline (pH 7.0) to remove blood and then washed with ice-cold saline, dried using filter paper, and weighed in a wet state. A portion of the liver was fixed with 4% paraformaldehyde, embedded in paraffin, and frozen. Another portion of the liver was snapfrozen in liquid nitrogen and stored at À701C until use for reverse transcription-PCR (RT-PCR) and immunoblots.
Serum Chemistries
Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglycerides (TGs), and FFAs were measured at Special Reference Laboratories (Osaka, Japan).
Histochemical and Immunohistochemical Analyses of the Rat Liver
Paraformaldehyde-fixed specimens were cut into 5-mm-thick sections and stained for 1 h with 0.1% (w/v) Sirius Red (Direct Red 80; Aldrich, Milwaukee, WI, USA), Oil red O, or hematoxylin and eosin (H&E). Immunohistochemistry was performed according to the methods described elsewhere. 26 Briefly, sections were deparaffinized, washed, and preincubated in blocking solution, followed by incubation with anti-4-HNE (15 mg/ml), HO-1 (1:50), CD68 (1:100), a-SMA (1:100), cytoglobin (1:400), or caspase-12 (1:100) antibodies. Sections were then incubated with HRP-conjugated secondary antibodies (1:1000), washed, covered with DAB, and counterstained with hematoxylin. Some of the immunostainings were performed at the Biopathology Institute (Oita, Japan). The red area on Oil red O staining was image analyzed by LuminaVision (Mitani Corporation, Tokyo, Japan).
TdT-Mediated dUTP Nick-End Labeling Assays
For the detection of apoptotic cells, paraffin-embedded sections were stained with the TdT-Mediated dUTP Nick-End Labeling (TUNEL) technique using an In Situ Apoptosis Detection kit (Takara Shuzo, Ohtsu, Japan) according to the manufacturer's instructions. For semi-quantitative analysis, the number of TUNEL-positive cells was counted in five randomly selected fields by viewing each slide at a magnification of Â 400, and the average number in each group was calculated, as described previously. 27 BrdU Assay for Hepatocyte Proliferation For the detection of hepatocyte proliferation, rats were i.p. injected with BrdU (100 mg/kg) 2 h before being killed. In situ detection of the incorporation of BrdU into the nuclei was conducted immunohistochemically. 28 For semi-quantitative analysis, as for TUNEL, the number of BrdU-positive cells was counted in five randomly selected fields by viewing each slide at a magnification of Â 200, and the average number in each group was calculated.
Quantitative RT-PCR mRNA expressions of tumor necrosis factor-alpha (TNF-a), transforming growth factor-beta 1 (TGF-b1), a-SMA, collagen 1A2 (COL1A2), matrix metalloproteinases (MMPs)-2, -9, and -13, tissue inhibitor of MMP-1 (TIMP-1), caspases-3, -7, -9, and -12, GRP78, interleukin-6 (IL-6), BAX, BAK, Bclxl, Bcl-2, and ERp57 were assessed by quantitative RT-PCR. Total RNA was extracted from liver tissues using Isogen (Nippon Gene, Tokyo, Japan). 29 The expression of mRNA was measured using TaqMan One-Step RT-PCR Master Mix Reagents (Applied Biosystems, Foster City, CA, USA) or using the One-Step SYBR RT-PCR Kit (Perfect Real Time; Takara Bio, Ohtsu, Japan), and Applied Biosystems Prism 7700 (Applied Biosystems) according to a previously reported procedure. 27 Primers and oligonucleotide probes were designed using Primer Express (Sigma Chemical), and are listed in Table 1 . Each PCR amplification was performed on five rats in both experimental and control groups. Individual gene expression was normalized by GAPDH. The conditions for the TaqMan One-Step RT-PCR were as follows: 30 min at 481C (stage 1, RT), 10 min at 951C (stage 2, RT inactivation and Ampli Taq Gold activation), and then 40 cycles of amplification for 15 s at 951C and 1 min at 601C (stage 3, PCR). The conditions for the One-Step SYBR RT-PCR (Perfect Real Time) were as follows: an initial step of 15 min at 421C, 2 min at 951C, and then 40 amplification cycles of denaturation at 951C for 15 s, and annealing and extension at 601C for 1 min.
Immunoblot Analysis
Some protein levels were assessed by immunoblot analysis, as described previously. 29 The liver tissue was lysed by RIPA buffer containing 50 mM Tris-HCl (pH 7.2), 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM EDTA, and 1 mM PMSF and then homogenized in ice-cold water. After centrifugation for 10 min at 41C and 12 000 r.p.m., the protein concentration of the obtained supernatant was determined using the Bio-Rad Dc protein Assay Reagent (Bio-Rad, Hercules, CA, USA). Protein was electrophoretically resolved in 10 or 12% SDS polyacrylamide gel, and successively transferred to Hybond-ECL nitrocellulose membranes. The membranes were blocked by 5% non-fat dietary milk solution in Tris-buffered saline (20 mM Tris and 150 mM NaCl, pH 7.4) with 0.1% Tween-20. They were then incubated overnight with primary antibodies at 41C and successively with secondary antibodies at room temperature for 1 h. The following dilutions of primary antibodies were used: mouse monoclonal antibody to a-SMA, 1:1000; rabbit polyclonal antibodies to cytoglobin, 1:200; rat monoclonal antibody to caspase-12, 1:200; goat polyclonal antibodies to GRP78, 1:200; rabbit polyclonal antibodies to caspase-7, 1:1000; rabbit polyclonal antibodies to cleaved caspase-7 (Asp198), 1:1000; rabbit polyclonal antibodies against PDI, 1:200; mouse monoclonal antibody to GAPDH, 1:30 000. Immune complexes were visualized using a SuperSignal West Pico Chemiluminescent Substrate (ECL, Pierce, Rockford, IL, USA). Finally, band intensity was determined by scanning video densitometry.
Statistical Analysis
All results are expressed as mean ± s.d. Statistical analysis was performed using Student's t-test (Po0.05 was considered significant).
RESULTS

Accumulation of Fat in the Liver and Recovery after Dietary Change
As shown in Figure 1a and b, Oil red O staining clearly indicated that the MCDD diet (group M) for 10 weeks induced fat accumulation in the liver, especially in hepatocytes. It was also recognized that fat accumulation immediately decreased in group R (Po0.01), whose diet was changed from MCDD to CD during the last 2 weeks. The serum level of FFA was reduced in group M (183 ± 31.6 mequiv./l) compared with control group C (274 ± 35.7 mequiv./l) and recovery group R (267±36.5 mequiv./l) (Po0.01). Similarly, the serum level of TG was reduced in group M (4.33±1.21 mg/dl) compared with control group C (23.5±4.95 mg/dl) and group R (28.2±4.97 mg/dl) (Po0.01) (Figure 1c and d, Po0.01). Changes in the body weights of rats in each group are presented in Supplementary  Table 2 .
Liver Histology and Kupffer Cell Activation H&E staining showed that the livers in group C showed an intact tissue structure, whereas those in group M showed the apparent vacuolization of hepatocytes, focal necrosis, and inflammatory cell accumulation in the parenchyma. These pathological changes were clearly improved in group R (Figure 2a ). In accordance with this histological recovery, serum levels of AST and ALT were reduced from 97.7±13.5 
Oxidative Stress and its Recovery in Steatohepatitis
We used the immunostaining of 4-HNE to detect the production of oxidative aldehyde by lipid peroxidation in the liver. As shown in Figure 3a , the control liver of group C exhibited negligible staining by anti-4-HNE antibodies. In contrast, the liver in group M showed brown-colored hepatocytes and stained cells also accumulated at necrotic foci (magnified area). The number of 4-HNE-positive cells and the amount of granulomatous accumulation in cells, presumably macrophages, were clearly reduced in group R. These results were reproduced on immunostaining of HO-1. As shown in Figure 3b , HO-1 expression is restricted in hepatic sinusoids, presumably in Kupffer cells (magnified area). However, in group M, HO-1-positive cells additionally led to an aggregation of cells next to vacuolized hepatocytes (magnified area). These reactions immediately disappeared in group R. In accordance with these results, HO-1 mRNA expression determined by RT-PCR was significantly augmented in group M compared with group C (5.19 ± 1.08 vs 3.13 ± 0.26, respectively, Po0.01) and returned to the normal level in group R.
Taken together, it can be stated that the accumulation of Oil red O-stained lipids, 4-HNE, and CD68-and HO-1-positive macrophages by administering an MCDD diet generates oxidative stress and hepatocyte damage (increase in AST and ALT levels), resulting in inflammatory gene expression, such as TNF-a. However, switching the diet from MCDD to CD immediately triggers the inhibition of inflammatory reactions.
Regression of Fibrosis and Hepatic Stellate Cell Activation in Steatohepatitis
Sirius Red staining (Figure 4a ) clearly revealed collagen deposition with C-C and P-C bridges, near to cirrhosis, in the fibrotic septum of group M, although collagen deposition was observed only around veins in the intact liver (group C). An immediate and marked recovery of this advanced fibrosis was observed in group R, indicating that the change in diet from MCDD to CD triggers the regression of fibrosis in the liver within 2 weeks.
Immunohistochemistry of a-SMA and cytoglobin, markers of activated stellate cells and liver myofibroblasts, showed that hepatic fibrotic cell activation occurred in group M, whereas the process ceased immediately in group R (Figure  4b and c). Immunoblot analyses confirmed these immunohistochemical observations (Figure 4d) . Furthermore, as shown in Figure 4e , RT-PCR analyses indicated that mRNA expressions of all a-SMA, TGF-b1, Col1A2, TIMP-1, MMP-2, and MMP-9 increased significantly in group M, and thereafter returned to the original level in group R. Conversely, the expression of MMP-13 decreased significantly in group M (0.98±0.30 vs 3.39±1.24, Po0.01) and recovered significantly in group R (2.30 ± 1.11). Thus, the recovery of fibrosis is evident at levels of histology, fibrotic protein, and fibrotic gene expression after switching the diet from MCDD to CD.
The Change of Hepatocyte Apoptosis and Proliferation TUNEL staining showed that the number of apoptotic hepatocytes slightly increased in group M compared with group C (68.2 ± 15.9 vs 40.3 ± 8.33 cells per field, respectively, Po0.05), whereas it decreased significantly in group R (48.0±6.48 cells per field) (Figure 5a and c) . Conversely, the in situ BrdU incorporation assay showed that the number of proliferated hepatocytes underwent no marked changes in group M compared with group C (7.5 ± 3 vs 7.6 ± 1.0 cells per field, respectively, P40.05), whereas it increased significantly in group R (17.2±4.35 cells per field) (Figure 5b and d) . Furthermore, the ratio of hepatocyte proliferation (BrdU-positive cells)/apoptosis (TUNEL-positive cells) decreased significantly in group M compared with control group C (0.10 ± 0.03 vs 0.19 ± 0.03, respectively, Po0.01), whereas it increased significantly in group R compared with group M (0.41 ± 0.09, Po0.01, Figure 5e ). In addition, as shown in Figure 5f , mRNA expression of IL-6, which is known to initiate hepatocyte growth through the STAT3 transcription factor, markedly decreased in group M and thereafter increased in group R, whereas STAT-3 expression remained unchanged (data not shown). Furthermore, mRNA expression of BAX and BAK, proapoptotic genes, markedly increased in group M and returned to the normal range in group R, whereas Bcl-xl and Bcl-2 mRNA expression remained unchanged (data not shown). These results suggest that hepatocyte proliferation/apoptosis undergoes a dynamic transition on changing the diet from MCDD to CD.
Involvement of ER Stress in Fibrosis of Steatohepatitis and its Recovery
Caspase-12 is known as a member of the IL-1b-converting enzyme subfamily of caspases. In rodents, the homolog of this gene mediates apoptosis in response to ER stress. Immunohistochemistry using anti-caspase-12 antibodies revealed that caspase-12 showed negligible expression in group C, whereas it was abundant in hepatocytes with fatty degeneration in group M, indicating the occurrence of ER stress in fatty hepatocytes (Figure 6a ). The dietary change clearly reduced the content of caspase-12 in hepatocytes (Figure 6a ).
Immunoblot analyses of ER stress-marker proteins such as caspase-12, caspase-7 and cleaved caspase-7, and GRP78 showed that all of these protein expressions were significantly increased in group M and successively reduced in group R (Figure 6b and c) . In addition, PDI, an ER-residing protein that catalyzes protein folding and thiol-disulfide interchange reactions, 30, 31 was markedly induced in group M compared with groups C and R (Figure 6d ).
RT-PCR analyses supported these observations by showing that mRNAs of GRP78, caspase-12, caspase-7, c-Jun, and ERp57 increased significantly in group C and decreased after 2 weeks of CD diet administration (Figure 6e ).
DISCUSSION
Hepatic Steatosis: the 'Primer' for Fibrosis of NASH Induced by MCDD As both methionine and choline are essential precursors of hepatic phosphatidylcholine synthesis, their deficiency provokes hepatic steatosis by limiting the availability of its substrates, which, in turn, inhibits VLDL assembly and blocks TG secretion from hepatocytes. 32, 33 Our study showed that serum levels of TG and FFA in MCDD-induced fatty liver fibrosis (group M) decreased to one-fifth and twothirds, respectively, of that in the CD group (group C), indicating the impaired secretion of TG and FFA from hepatocytes. Hepatic steatosis facilitates the mitochondrial uptake of FFA, the overflow of which triggers b-oxidation, resulting in the generation of reactive oxygen radicals to trigger lipid peroxidation. 34, 35 This leads to the production of toxic substances that damage the mitochondria and stimulate further production of reactive oxygen species. 34 Such a positive feedback loop results in cellular damage, activation of liver macrophages (Kupffer cells), and generation of proinflammatory cytokines that initiate hepatic inflammation. 36, 37 Kupffer cells could be the main source of TNF-a in MCDD-induced liver injury. In addition, MMP-9 (gelatinase B), a member of MMPs, is derived mainly from Kupffer cells in the liver, 38 and its expression is significantly increased together with the activation of cells, indicating that MMP-9 could be a marker of Kupffer cell activation instead of its activity as a collagenase. A number of studies have shown increased serum and plasma levels of MMP-9 in various types Pathophysiology of steatohepatitis Y-p Mu et al of liver injury, including ischemic reperfusion injury 39 and chronic viral hepatitis. 40, 41 Furthermore, the mutation of MMP-9 was reported to inhibit hepatic fibrogenesis in mice. 42 This study showed that MMP-9 and TNF-a mRNA expression increased significantly with the activation of Kupffer cells that were positive for CD68 in group M, whereas switching the diet from MCDD to CD triggered the immediate recovery of MMP-9, suggesting that MMP-9 is associated with the activation status of Kupffer cells.
In contrast, Kupffer cells have been reported to have an important role in the regression of fibrosis through the expression of MMP-13 in other experimental models. 43, 44 The current study showed that the number of CD68-and HO-1-positive cells, which are identical to activated Kupffer cells, significantly increased in group M, whereas MMP-13 mRNA expression markedly decreased. Switching the diet from MCDD to CD triggered the immediate recovery of the liver histology, accompanied by a marked increase in the expression of MMP-13 mRNA, indicating the active role of MMP-13 derived from Kupffer cells in the regression of liver fibrosis. 45 Stellate Cell Activation: a Crucial Role in Fibrosis Development in NASH Hepatic stellate cells are present in the normal liver in a quiescent state, and their major function seems to be the storage of vitamin A. After injury, stellate cells activate or trans-differentiate into proliferating myofibroblast-like cells that produce abundant levels of fibrillar collagen and TIMP-1. 46 The secretion of abundant levels of TIMP-1 by activated stellate cells inhibits hepatic collagenase activity, and thereby promotes a net increase in extracellular matrix materials. TIMP-1 also promotes hepatic fibrogenesis by inhibiting the apoptosis of activated stellate cells. 47 MMP-2 (gelatinase A), derived mainly from activated stellate cells, is involved in degradation of the basement membrane in the early stage of liver fibrosis. 48 This study showed that both hepatic collagen deposition and stellate cell activation markers, such as a-SMA and cytoglobin, increased significantly with a markedly elevated expression of Col1A2, TIMP-1, MMP-2, and TGFb-1 mRNAs. After switching to CD feeding, hepatic collagen deposition decreased significantly, accompanied by the marked reduction of these mRNAs, suggesting that MCDD-induced fatty liver fibrosis was closely related to stellate cell activation.
ER Stress: an Important Participant in Advancement of Liver Fibrosis in NASH Obesity is associated with the induction of ER stress predominantly in the liver and adipose tissues. 49 Previous research has shown that fatty liver induced by a high sucrose diet and high saturated fat diet shows clear ER stress events in a rodent model. 50 In addition, CHOP (a key component in ER stress-mediated apoptosis) deficiency attenuates cholestasis-induced liver fibrosis by reducing hepatocyte injury in bile duct ligation mice. 51 However, the roles of ER stress in fatty liver induced by MCDD have not been reported. Initial mediators of ER stress responses are ER resident type I transmembrane serine/threonine protein kinases, PKR-like ER kinase, and inositol-requiring enzyme-1 (IRE-1) ; the accumulation of unfolded proteins in ER induces the oligomerization-dependent autophosphorylation of these kinases, 52, 53 and thereby initiates cytoplasmic signal transduction. It was recently shown that activated IRE-1 on the ER membrane recruits TNF receptor-associated factor 2, and thus activates c-Jun amino-terminal kinase. 54 In addition, the survival response activates genes that encode ER-residing chaperones such as GRP78/Bip, which uses energy derived from ATP hydrolysis to prevent the aggregation of ER proteins and is considered the classical marker of UPR activation. 55 The current study showed that the expression of ER stress markers GRP78 (protein and mRNA) and c-Jun mRNA increased significantly in the MCDD group, whereas the expression of all of them decreased markedly after changing the diet. Another ER stress-related molecule, PDI, 30, 31 showed similar behavior (Figure 6d and e) . Thus, ER stress may be a key factor in MCDD-induced fatty liver fibrosis.
Caspases also participate in ER stress-induced apoptosis. In mice, procaspase-12 is localized on the cytoplasmic side of the ER and is cleaved and activated specifically by ER stress, but not by death receptor or mitochondria-mediated apoptotic signals. 56 Caspase-7, which translocates from the cytosol to the cytoplasmic side of the ER membrane in response to ER stress, has been reported to interact with and cleave procaspase-12, leading to its activation. 57 Activated caspase-12 then cleaves and activates procaspase-9, which in turn activates the downstream caspase cascade, including caspase-3, DNA fragmentation, and cell death. 58 Our results also showed that protein and gene expressions of caspase-12, caspase-7, and cleaved caspase-7 were significantly elevated during steatohepatitis together with the increased number of apoptotic hepatocytes, whereas they were reduced markedly after changing the diet. Furthermore, although the proliferation of hepatocytes did not show a clear change in the MCDD group, the ratio of hepatocyte proliferation/apoptosis decreased significantly, whereas it increased markedly after changing the diet to CD, indicating that the apoptotic caspase-12 pathway may also inhibit hepatocyte proliferation in MCDD-induced steatohepatitis. The marked elevation of BAX and BAK may also participate in stimulating the apoptosis of hepatocytes by MCDD.
In conclusion, this study shows that, although the underlying mechanisms involved in MCDD-induced fatty liver fibrosis are complicated, they may include not only wellknown factors, such as steatosis, oxidative stress, and the activation of Kupffer and stellate cells, but also ER stresses and the balance between hepatocyte proliferation and apoptosis. The reversibility of liver fibrosis is also shown in steatohepatitis, at least in the present MCDD model.
